News Agency
Men's Weekly

Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A

  • Written by PR Newswire

SHANGHAI, Jan. 3, 2024 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced the completion of first subject dosing in its registrational clinical trial (CTR20233400) of BBM-H803, a gene therapy for hemophilia A, independently developed and produced by Belief BioMed.

BBM-H803...

Read more: Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial...

Hard Chrome Plating: Enhancing Durability And Performance In Industrial Components

In industries where equipment is exposed to constant friction, pressure, and harsh operating conditions, surface protection becomes critical to performance and longevity. Hard chrome plating is a specialised surface treatment process widely used to improve wear resistance, reduce friction, and extend... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion